Topical Androgen Receptor Inhibitors Market - Top Companies and Manufacturers

Companies Dominating the Topical Androgen Receptor Inhibitors Market

Cosmo Pharmaceuticals
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Suzhou Kintor Pharmaceuticals Inc
Sun Pharmaceutical Industries Limited
Aranda Pharma Ltd
Selleck Chemicals

Browse Key Market Insights with Data Illustration:

Topical Androgen Receptor Inhibitors Market Size & Share, Global Forecast Report 2037

In the News

Aug 2020- The U.S. FDA has approved the first-in-class androgen receptor inhibitor, carotene cream 1% (Winlevi, Cassiopea), for the treatment of acne vulgaris in individuals 12 years of age and older.
Apr 2021- The National Medical Products Administration has given the green light for Kintor Pharmaceutical, a clinical-stage biotechnology company developing novel small molecule and biological therapeutics, to start GT20029 (gel/tincture) clinical trials for the treatment of androgenetic alopecia and acne.
Nov 2023- The supplemental new drug application for XTANDI® has been approved by the U.S. Food and Drug Administration (FDA), as announced by Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. With this approval, XTANDI turns out the first and only androgen receptor signaling inhibitor authorized by the FDA for the management of patients with biochemically driven recurrence of nonmetastatic castration-sensitive prostate cancer (nmCSPC) who are at high risk of developing metastatic disease.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of topical androgen receptor inhibitors is evaluated at USD 58.45 million.

The topical androgen receptor inhibitors market size was over USD 51.72 million in 2024 and is poised to exceed USD 329.18 million by 2037, growing at over 15.3% CAGR during the forecast period i.e., between 2025-2037. Rising aging population, growing healthcare spending and rising acceptance of cosmetic procedures will drive the market growth.

North America industry is estimated to hold largest revenue share of 34% by 2037, due to rising demand for cosmetic operations in the region.

The major players in the market are Cosmo Pharmaceuticals, Suzhou Kintor Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Aranda Pharma Ltd, Selleck Chemicals, Astellas Pharma, Takeda Pharmaceutical, and Daiichi Sankyo.

Topical Androgen Receptor Inhibitors Market - Top Companies and Manufacturers

Companies Dominating the Topical Androgen Receptor Inhibitors Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the topical androgen receptor inhibitors market?

Why is the topical androgen receptor inhibitors sector gaining traction in near future?

Which region accounted for the largest topical androgen receptor inhibitors industry share?

Who are the major topical androgen receptor inhibitors players?